via Stanford University
A wireless system developed by Assistant Professor Ada Poon uses the same power as a cell phone to safely transmit energy to chips the size of a grain of rice. The technology paves the way for new “electroceutical” devices to treat illness or alleviate pain.
The Latest on: Electroceutical devices
via Google News
The Latest on: Electroceutical devices
- Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Productson May 20, 2022 at 12:37 am
“Engaging NAMSA as strategy advisors to develop and apply proven medical device reimbursement strategies is a huge advantage for Endonovo and our shareholders, according to Endonovo CEO Alan ...
- $5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursementon May 9, 2022 at 11:28 pm
“The device has shown no known adverse effects in almost 18 ... (CE518057), which allows it to be marketed in the European Union for: “the manufacture of electroceutical therapy systems for the ...
- $5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursementon May 9, 2022 at 9:26 pm
“The device has shown no known adverse effects ... “the manufacture of electroceutical therapy systems for the promotion of wound healing, reduction of pain and post-operative edema”.
- Smaller, Faster, Cheaper: Chip Technology for Medical Deviceson May 4, 2022 at 5:01 pm
Equally important, we need probes that help us better understand the effect of those electroceutical therapies--probes that ... to small handheld devices such as the MinION from Oxford Nanopore ...
- Healing with "Electroceuticals": Interview with BioElectronics Executive Vice President Dr. Deepak Kotakon April 27, 2022 at 5:00 pm
Dr. Deepak Kotak: Electroceutical (like nutraceutical) is a broad term that describes a category of devices that use electricity to heal body tissues. The devices use a variety of forms of ...
- Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo ...on April 25, 2022 at 6:28 am
The Company's noninvasive Electroceutical® therapeutic device, SofPulse ®, which uses pulsed short-wave radiofrequency at 27.12 MHz, has been FDA-cleared and CE marked for the palliative ...
- A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart Failureon April 21, 2022 at 3:54 am
Parasym™ is the only company to have developed a device that utilises advances in electroceutical technology to provide ground-breaking non-invasive treatment for numerous health and wellness ...
- Electroceuticals jolt into the clinic, sparking autoimmune opportunitieson April 18, 2022 at 5:00 pm
They are chasing SetPoint Medical, which is also testing an immune-modulating electroceutical device for rheumatoid arthritis. But whereas SetPoint’s device acts on the vagus nerve, which ...
via Bing News
